[ad_1] SAN DIEGO, Dec. 7, 2024 /PRNewswire/ — The Shareholders Foundation, Inc. announced that a lawsuit was filed for certain investors in DMC Global Inc. (NASDAQ: BOOM) shares Investors who purchased more than $100,000 in […]
Tag: Inc.
EpiVax Drives Immunogenicity Innovation in 2024: Year in Review
[ad_1] PROVIDENCE, R.I., Dec. 7, 2024 /PRNewswire/ — EpiVax, Inc., a leader in preclinical immunogenicity risk assessment for biologic and peptide therapeutics, celebrates a productive 2024 marked by scientific innovation, service diversification, and corporate growth. This […]
EpiVax Drives Immunogenicity Innovation in 2024: Year in Review
[ad_1] PROVIDENCE, R.I., Dec. 6, 2024 /PRNewswire/ — EpiVax, Inc., a leader in preclinical immunogenicity risk assessment for biologic and peptide therapeutics, celebrates a productive 2024 marked by scientific innovation, service diversification, and corporate growth. This […]
Charles R. Scheper, Chairman of Bexion Pharmaceuticals Board, Named Great Living Cincinnatian
[ad_1] COVINGTON, Ky., Dec. 6, 2024 /PRNewswire/ — Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to treat solid tumor cancers and chemotherapy-induced peripheral neuropathy (CIPN), today announced that its […]
EpiVax Highlights Partnerships and New Research from Clínica Esperanza and GAIA Vaccine Foundation
[ad_1] PROVIDENCE, R.I., Dec. 6, 2024 /PRNewswire/ — EpiVax, a leader in biotechnology known for its advanced immunoinformatics tools, proudly announces its continued support for two nonprofits, Clínica Esperanza/Hope Clinic and GAIA Vaccine Foundation. EpiVax supports these […]
